Schonfeld Strategic Advisors LLC lowered its position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) by 93.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 22,193 shares of the company's stock after selling 344,207 shares during the period. Schonfeld Strategic Advisors LLC's holdings in Alpha Teknova were worth $185,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Nkcfo LLC bought a new position in Alpha Teknova in the 4th quarter worth about $501,000. Invesco Ltd. bought a new position in Alpha Teknova in the 4th quarter worth about $9,236,000. Raymond James Financial Inc. bought a new position in Alpha Teknova in the 4th quarter worth approximately $716,000. China Universal Asset Management Co. Ltd. bought a new position in Alpha Teknova in the 4th quarter worth approximately $94,000. Finally, Mount Lucas Management LP bought a new position in Alpha Teknova in the 4th quarter worth approximately $75,000. Institutional investors own 13.81% of the company's stock.
Alpha Teknova Stock Performance
Shares of TKNO opened at $6.52 on Thursday. The firm has a 50-day moving average price of $5.81 and a 200 day moving average price of $7.11. The firm has a market capitalization of $348.44 million, a PE ratio of -8.81 and a beta of 0.50. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12. Alpha Teknova, Inc. has a 52-week low of $1.16 and a 52-week high of $10.37.
Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.02. The business had revenue of $9.60 million during the quarter, compared to analysts' expectations of $9.41 million. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. On average, sell-side analysts anticipate that Alpha Teknova, Inc. will post -0.58 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Craig Hallum started coverage on Alpha Teknova in a research note on Monday, February 10th. They issued a "buy" rating and a $12.00 price target for the company.
Check Out Our Latest Report on Alpha Teknova
Alpha Teknova Company Profile
(
Free Report)
Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Alpha Teknova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Teknova wasn't on the list.
While Alpha Teknova currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
